AbbVie Selling $15 Billion Bonds to Buy ImmunoGen, Cerevel bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
(Bloomberg) Pharmaceutical giant AbbVie Inc. sold $15 billion of bonds in the US investment-grade market on Thursday to help fund its acquisitions of ImmunoGen Inc. and Cerevel Therapeutics Holdings Inc., adding to a recent rush of buyout financings. Most Read from BloombergNvidia Rises Most in About Nine Months as AI Drives SalesStocks Rally as AI Craze Sweeps Across the World: Markets WrapT-Bills Without Tax Bills? This Fund Says It Cracked the CodeAT&T Says Mobile Network Restored as US St